As of June 2024 10x Genomics has a market cap of $2.68 Billion. This makes 10x Genomics the world's 3664th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.68 B | -59.43% |
2023 | $6.61 B | 58.59% |
2022 | $4.17 B | -74.93% |
2021 | $16.63 B | 9.21% |
2020 | $15.23 B | 107.63% |
2019 | $7.33 B |
On Jun 1st, 2024 the market cap of 10x Genomics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $12.77 M | -99.52% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | -85.84% | ๐ฌ๐ง UK |
Novavax NVAX | $2.21 B | -17.51% | ๐บ๐ธ USA |
Novocure
NVCR | $2.36 B | -11.75% | Jersey |